Brief: Ainos Publishes Preclinical Data On VELDONA Formulation's Potential

Ainos

21/11/2022 11:43

Nov 21 (Reuters) - Ainos Inc  AIMD.O :
    * AINOS PUBLISHES PRECLINICAL DATA DEMONSTRATING ITS VELDONA
FORMULATION'S POTENTIAL AS TREATMENT CANDIDATES FOR THE MOST
COMMON MEDICAL CONDITIONS FOR COMPANION ANIMALS
    * AINOS INC - ADVANCES ITS PRODUCT PIPELINE AS IT TARGETS
COMMENCING CLINICAL STUDIES DURING Q2 OF 2023
    * AINOS INC - INTENDS TO BEGIN CLINICAL STUDIES TO ASSESS
VELDONA'S POTENTIAL USE IN TREATMENT OF FCGS AND CANINE ATOPIC
DERMATITIS DURING Q2 OF 2023
    * AINOS INC - BASED ON VELDONA'S EFFECTIVE ANTIVIRAL
EFFICACY, CO
IS PLANNING AN EXPANSION OF ITS USE FOR TREATMENT OF HUMANS TO
TREATMENT OF ANIMALS

Source text for Eikon:  ID:nPn6qqMnga 
Further company coverage:  AIMD.O 
 ((Reuters.Briefs@thomsonreuters.com;))